Operating profit before deduction of amortization: Kezar Life Sciences Inc. (KZR)
Dependence on rigid protocols within the inhibitor ecosystem creates risks that the aggregate EBITDA of Kezar Life Sciences (KZR) on GURU.Markets reflects through volatility, where 0.00 shows the current value of the metric. Fierce competition for patients in immunotherapy complicates growth, yet the development of selective drugs to combat autoimmune pathologies provides Kezar Life Sciences (KZR) with the potential to scale its business.
Summary analytical data breakdowns for Kezar Life Sciences Inc. (KZR)
- current quotes and average value forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- company total debt and liquidity indicators:
Debt to Capital Kezar Life Sciences|KZR - Long-Term Debt to Equity|Short-Term Debt to Capital Kezar Life Sciences, Inc|KZR - Company Aggregate Debts|Debts to Book Value Kezar Life Sciences, Inc|KZR - Company Long-Term Liabilities|Current Liabilities Kezar Life Sciences|Quick Ratio kezarlifesciences.com
- business earnings and investment ratios data:
KZR - Company Net Income|Expected Net Income Kezar Life Sciences|KZR - Price to Earnings Ratio|Future Price to Earnings Multiple Kezar Life Sciences Inc.|KZR - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc.|KZR - Operating profit EBITDA|Net earnings per share for the last four quarters Kezar Life Sciences|KZR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share trend for the last twelve months kezarlifesciences.com|KZR - Earnings growth in current year|Expected net earnings per share growth next year Kezar Life Sciences
- sales and revenue data:
Summary company analytics:Kezar Life Sciences
For Kezar Life Sciences (KZR), which utilizes outsourcing for development and production, the current EBITDA level reflects the efficiency of operating expense management without the burden of capital expenditures. This metric is calculated as the sum of operating profit and depreciation, demonstrating the actual cash flow from core operations; its decline signals rising contract costs, while stability confirms the financial resilience of the business.
Competitor analysis for Kezar Life Sciences
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics Inc.)|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|Climb Bio Inc. (CLYM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZURA (Zura Bio)|Operating profit before deduction of amortization ATYR|ADAG: Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization Shattuck Therapeutics|Operating profit EBITDA EQ (Equillium Inc)|Company profit before taxes, interest and amortization CNTB (Connect Pharma)|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atarabio.com ATRA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization adicetbio.com|CELU: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization INmune Bio Corporation (INMB)|Operating profit before deduction of amortization Barinthus Biotherapeutics Corp BRNS|Operating profit EBITDA SABS (SAB Biotherapeutics)|Operating profit EBITDA akaritx.com AKTX|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
